Dermatology
Photodermatosis
Differentiate idiopathic (PMLE, solar urticaria), drug-induced, autoimmune (lupus), genetic; sun avoidance + targeted therapy.
Source: BAD
Used in: Anaphylaxis & Allergy
Step 1 of ~6
question
Pattern Recognition
Different photodermatoses different management.
Related
Curated clinical cross-links plus same-class fallbacks.
Drugs
- Lutetium-177 PSMA-617 · PSMA-Targeted Radioligand Therapy
- Phenylephrine · Alpha-1 Adrenergic Agonist (Pure Vasoconstrictor)
- Inclisiran · PCSK9-targeted siRNA
- Azathioprine · Systemic Immunosuppressant — Eczema / Autoimmune Dermatoses
- Hydroxychloroquine · Antimalarial — Lupus / Dermatoses
- Mycophenolate Mofetil · Systemic Immunosuppressant — Bullous Diseases / Autoimmune Dermatoses
Pathways
- Suspicious Pigmented Lesion — Melanoma Pathway · NICE NG14 2015 / BAD
- Cellulitis and Erysipelas · NICE NG141 2019 / CREST
- Psoriasis — Severity Assessment and Step-Up Therapy · NICE NG153 2019 / BAD
- Atopic Eczema — Assessment and Step-Up Therapy · NICE NG95 2023
- Urticaria and Angioedema · BSACI / EAACI Guidelines 2022
- Acne Vulgaris — Grading and Treatment · NICE NG198 2021 / BAD
Decision support only. Always apply local guidelines and clinical judgement.